Biosensors

Biosensors: According to Bloomberg, Citic Private Equity Funds Management Co. is considering buying full control of medical devices maker Biosensors International Group Ltd., said two people with knowledge of the deliberations. The Beijing-based firm, an arm of China’s state-backed Citic Group Corp. conglomerate, is in talks with several banks about financing for a deal. It owns about 22% of the Singapore-listed company, which has a market value of $1.5b. Citic Private Equity is considering an offer for the rest of Biosensors. The Chinese private-equity firm bought the stake in Biosensors in Nov '13 from Shandong Weigao Group Medical Polymer Co. for $312.3m, or S$1.05 per share, according to exchange filings.